A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function

Recruiting

Phase 1

VepdegestrantA Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function

Sponsor:

Pfizer

Code:

NCT07231991

Conditions

Healthy Participants

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Accepted

Interventions

vepdegestrant

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-09. This information was provided to ClinicalTrials.gov by Pfizer on 2026-04-03.